Klemp Walter Vinsider trades
In SEC Form 4 filings, Klemp Walter V is listed as CEO and President of Moleculin Biotech, Inc. (MBRX) and Director of Autonomix Medical, Inc. (AMIX). Klemp Walter V reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-08
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| MBRXMoleculin Biotech, Inc. | Oct 15 | Oct 16 | M | 207,500 | not reported | not reported | 771,840 | No | Form 4 |
| MBRXMoleculin Biotech, Inc. | Oct 15 | Oct 16 | F | 48,659 | $0.37 | $18,009 | 723,181 | No | Form 4 |
| MBRXMoleculin Biotech, Inc. | Oct 15 | Oct 16 | A · derivative | 415,000 | $0.37 | $153,592 | 2,341,335 | No | Form 4 |
| MBRXMoleculin Biotech, Inc. | Oct 15 | Oct 16 | A · derivative | 415,000 | not reported | not reported | 2,756,335 | No | Form 4 |
| MBRXMoleculin Biotech, Inc. | Oct 15 | Oct 16 | M · derivative | 207,500 | $0.00 | $0 | 2,548,335 | No | Form 4 |
| AMIXAutonomix Medical, Inc. | Sep 3 | Sep 8 | A | 13,000 | not reported | not reported | 20,118 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.